Literature DB >> 17924141

Immunohistochemical expression of estrogen receptors alpha and beta in lobular neoplasia.

Aphrodite Nonni1, Flora Zagouri, Theodoros N Sergentanis, Andreas C Lazaris, Efstratios S Patsouris, George C Zografos.   

Abstract

The designation lobular neoplasia (LN) of the breast includes atypical lobular hyperplasia and lobular carcinoma in situ. Estrogen receptors (ER) play a significant role in breast carcinogenesis. In the present study, ER-alpha and ER-beta status are evaluated in 30 breast tissue specimens from patients whose main lesion was LN. A standard immunohistochemical procedure, using monoclonal antibodies for ER-alpha and ER-beta, was applied to the lesion and the adjacent normal breast tissues, the latter serving as control. In all cases, both receptors were expressed in LN as well as in normal breast ducts and lobules. Concerning ER-alpha, the Allred score and the percentage of ER-alpha-positive cells were significantly higher in LN than in the adjacent normal breast tissue. On the contrary, regarding ER-beta, the Allred score and the percentage of ER-beta-positive cells were significantly lower in LN compared with normal adjacent breast tissue. Greater increase in the percentage of ER-alpha-positive cells was associated with a smaller reduction in the percentage of ER-beta-positive cells and vice versa (Spearman's rho = -0.5044, p = 0.001). In conclusion, upregulation of ER-alpha and downregulation of ER-beta may represent two discrete molecular events in LN pathogenesis. Of notice, a mutually limiting interaction may exist between the two events.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17924141     DOI: 10.1007/s00428-007-0504-6

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  25 in total

Review 1.  Estrogen receptor beta--a new dimension in estrogen mechanism of action.

Authors:  J A Gustafsson
Journal:  J Endocrinol       Date:  1999-12       Impact factor: 4.286

2.  Biomarker profile and genetic abnormalities in lobular carcinoma in situ.

Authors:  Syed K Mohsin; Peter O'Connell; D Craig Allred; Arlene L Libby
Journal:  Breast Cancer Res Treat       Date:  2005-04       Impact factor: 4.872

3.  Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.

Authors:  Dan Tong; Eva Schuster; Michael Seifert; Klaus Czerwenka; Sepp Leodolte; Robert Zeillinger
Journal:  Breast Cancer Res Treat       Date:  2002-02       Impact factor: 4.872

4.  Quantification of estrogen receptor alpha and beta expression in sporadic breast cancer.

Authors:  I Bièche; B Parfait; I Laurendeau; I Girault; M Vidaud; R Lidereau
Journal:  Oncogene       Date:  2001-12-06       Impact factor: 9.867

5.  Co-localization of oestrogen receptor beta and leukocyte markers in the human cervix.

Authors:  D Stygar; H Wang; Y S Vladic; G Ekman; H Eriksson; L Sahlin
Journal:  Mol Hum Reprod       Date:  2001-09       Impact factor: 4.025

6.  Is invasive lobular carcinoma different from invasive ductal carcinoma?

Authors:  H Mersin; E Yildirim; K Gülben; U Berberoğlu
Journal:  Eur J Surg Oncol       Date:  2003-05       Impact factor: 4.424

7.  Biologic markers in axillary node-negative breast cancer: differential expression in invasive ductal carcinoma versus invasive lobular carcinoma.

Authors:  Ana Maria Gonzalez-Angulo; Aysegul Sahin; Savitry Krishnamurthy; Ying Yang; Shu-Wan Kau; Gabriel N Hortobagyi; Massimo Cristofanilli
Journal:  Clin Breast Cancer       Date:  2006-12       Impact factor: 3.225

8.  Decreased expression of estrogen receptor beta protein in proliferative preinvasive mammary tumors.

Authors:  P Roger; M E Sahla; S Mäkelä; J A Gustafsson; P Baldet; H Rochefort
Journal:  Cancer Res       Date:  2001-03-15       Impact factor: 12.701

9.  Genetic similarities and differences between lobular in situ neoplasia (LN) and invasive lobular carcinoma of the breast.

Authors:  Luca Morandi; Gianluca Marucci; Maria P Foschini; Maria G Cattani; Annalisa Pession; Cristina Riva; Vincenzo Eusebi
Journal:  Virchows Arch       Date:  2006-04-13       Impact factor: 4.064

10.  Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Authors:  X Sastre-Garau; M Jouve; B Asselain; A Vincent-Salomon; P Beuzeboc; T Dorval; J C Durand; A Fourquet; P Pouillart
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

View more
  6 in total

1.  Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.

Authors:  Fritcher Emily G Barr; Amy C Degnim; Lynn C Hartmann; Derek C Radisky; Judy C Boughey; Stephanie S Anderson; Robert A Vierkant; Marlene H Frost; Daniel W Visscher; Carol Reynolds
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-05

2.  Biologic characteristics of premalignant breast disease.

Authors:  Kimberly Cole; Maria Tabernero; Karen S Anderson
Journal:  Cancer Biomark       Date:  2010       Impact factor: 4.388

3.  Expression of estrogen receptor alpha and beta in breast cancers of pre- and post-menopausal women.

Authors:  Blanca Murillo-Ortiz; Elva Pérez-Luque; J M Malacara; Leonel Daza-Benítez; Martha Hernández-González; Luis Benítez-Bribiesca
Journal:  Pathol Oncol Res       Date:  2008-08-28       Impact factor: 3.201

4.  Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy.

Authors:  Hilda Wong; Silvia Lau; Polly Cheung; Ting Ting Wong; Andrew Parker; Thomas Yau; Richard J Epstein
Journal:  BMC Cancer       Date:  2014-11-10       Impact factor: 4.430

Review 5.  Molecular drivers of lobular carcinoma in situ.

Authors:  Greg J Logan; David J Dabbs; Peter C Lucas; Rachel C Jankowitz; Daniel D Brown; Beth Z Clark; Steffi Oesterreich; Priscilla F McAuliffe
Journal:  Breast Cancer Res       Date:  2015-06-04       Impact factor: 6.466

6.  Heat shock protein90 in lobular neoplasia of the breast.

Authors:  Flora Zagouri; Afrodite Nonni; Theodoros N Sergentanis; Christos A Papadimitriou; Nikolaos V Michalopoulos; Andreas C Lazaris; Efstratios Patsouris; George C Zografos
Journal:  BMC Cancer       Date:  2008-10-28       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.